Health Bulletin Haiti: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Bulletin Haiti.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 10, 2025

September 10, 2025

Beacon Therapeutics to Participate in the 2025 Bank of America Healthcare Trailblazers Private Company Conference

GlobeNewswire

September 10, 2025

CoRegen, Inc. Strengthens Leadership Team with the Appointments of Sonja Nelson as Chief Financial Officer and Peter Gelinas as Chief Technical Officer

GlobeNewswire

September 10, 2025

ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes

GlobeNewswire

September 10, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

GlobeNewswire

September 10, 2025

Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market

GlobeNewswire

September 10, 2025

Three CorVel Partners Recognized as 2025 Theo Award Winners for Excellence in Workers’ Compensation

GlobeNewswire

September 10, 2025

Relmada Issues Mid-Year CEO Letter to Shareholders

GlobeNewswire

September 10, 2025

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting

GlobeNewswire

September 10, 2025

Purespring Therapeutics to Participate in the 2025 BofA Healthcare Trailblazers Private Company Conference

GlobeNewswire

September 10, 2025

Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit

GlobeNewswire

September 10, 2025

OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System

GlobeNewswire

September 10, 2025

Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)

GlobeNewswire

September 10, 2025

CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders

GlobeNewswire

September 10, 2025

PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

GlobeNewswire

September 10, 2025

Immuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on September 25

GlobeNewswire

September 10, 2025

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

GlobeNewswire

September 10, 2025

BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia

GlobeNewswire

September 10, 2025

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation

GlobeNewswire

September 10, 2025

Medāna Brings Its Risk-Based AI Platform to Poland, Advancing Patient-Centered Healthcare Across Europe

GlobeNewswire

September 10, 2025

Medāna uruchamia w Polsce swoją platformę analizy ryzyka bazującą na sztucznej inteligencji – poszerzając ofertę zorientowanej na pacjenta opieki medycznej w całej Europie

GlobeNewswire